Edward John Allera | Buchanan Ingersoll & Rooney PC

SEP 13 2022

SCT's and Bad Evidence Generation: 4 Solutions to Combat its Permeation into the Drug Approval Process

EDWARD JOHN ALLERA

FDA & BIOTECHNOLOGY LIFE SCIENCES

MAY 4 2021

Legal Innovators Interview Series - The General Counsel at Covis Pharma Discusses the World of Pharmaceutical Approvals Around the Globe - Corporate Counsel

EDWARD JOHN ALLERA MATTHEW L. FEDOWITZ

FDA & BIOTECHNOLOGY INTELLECTUAL PROPERTY

APR 26 2021

Life Sciences Executive Exchange Series - Webinar Recap

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA MATTHEW L. FEDOWITZ RAQUEL (ROCKY) A. RODRIGUEZ RICHARD DISTEFANO

FDA & BIOTECHNOLOGY LIFE SCIENCES

NOV 30 2020

Operating at Warp Speed: Key Takeaways From COVID-19 Clinical Trials

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

CORONAVIRUS (COVID-19) HEALTHCARE LIFE SCIENCES

NOV 17 2020

Leaders in Life Sciences Key Takeaways

EDWARD JOHN ALLERA

CORONAVIRUS (COVID-19) HEALTHCARE LIFE SCIENCES

JUL 21 2020

Life Sciences Playbook - Navigating Operational and Regulatory Challenges While Emerging from the COVID-19 Pandemic

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA MATTHEW L. FEDOWITZ TINA HU-RODGERS

FDA & BIOTECHNOLOGY LIFE SCIENCES

JUL 7 2020

Top 10 Investor Insights on Life Sciences Post-COVID-19

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

MAY 18 2020

Increasing Revenue and Decreasing Costs as Life Sciences Companies Emerge From COVID-19

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY HEALTHCARE LIFE SCIENCES

APR 22 2020

Make Your Voice Heard in Washington Amid the COVID-19 Pandemic

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA MICHAEL P. STRAZZELLA

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY GOVERNMENT RELATIONS & PUBLIC POLICY LIFE SCIENCES

APR 9 2020

In the Chaos of COVID-19 Pandemic, What is "Current" in cGMP?

EDWARD JOHN ALLERA WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

MAR 23 2020

Clinical Trial Data in the Time of COVID-19

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA WILLIAM A. GARVIN

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

MAR 18 2020

FDA’s Coronavirus Triage – How Pharma Can Work With the Agency to Tackle a Pandemic

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

CORONAVIRUS (COVID-19) FDA & BIOTECHNOLOGY LIFE SCIENCES

FEB 6 2020

eBook: NDA 2.0 – The Changing World of New Drug Applications and How to Successfully Play in the Middle Ground

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA MATTHEW L. FEDOWITZ

FDA & BIOTECHNOLOGY INTELLECTUAL PROPERTY LIFE SCIENCES

MAY 15 2019

From White Oak with Love
An Attendee’s Perspective of the Reagan-Udall Foundation for the FDA Annual Meeting

EDWARD JOHN ALLERA

FDA & BIOTECHNOLOGY LIFE SCIENCES

JUN 3 2018

A Practical Approach for Resolving the Pediatric Oncology Drug Labeling Crisis

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

FDA & BIOTECHNOLOGY LIFE SCIENCES

AUG 31 2017

FDA Reaffirms Its Commitment to the Approval of Stem Cell Therapies Amidst Enforcement Actions Against "Unscrupulous Actors"

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

FDA & BIOTECHNOLOGY LIFE SCIENCES

FEB 10 2017

TrumpCare: The Pharmaceutical Industry and FDA

EDWARD JOHN ALLERA

FDA & BIOTECHNOLOGY GOVERNMENT RELATIONS & PUBLIC POLICY LIFE SCIENCES

JAN 23 2017

Regenerative Medicine in the Trump Era

EDWARD JOHN ALLERA

FDA & BIOTECHNOLOGY GOVERNMENT RELATIONS & PUBLIC POLICY LIFE SCIENCES

OCT 23 2015

Executive Leaders Radio - October 21, 2015

EDWARD JOHN ALLERA KATHRYN A. KRONQUIST MICHAEL P. STRAZZELLA

SEP 24 2015

Executive Leaders Radio - September 30, 2015

EDWARD JOHN ALLERA MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

JUL 1 2015

FDA Practice Partners With FGR Practice to Deliver Successful Client Outcomes

EDWARD JOHN ALLERA MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

GOVERNMENT RELATIONS & PUBLIC POLICY

JUN 3 2015

Executive Leaders Radio - June 3, 2015

EDWARD JOHN ALLERA MICHAEL P. STRAZZELLA WILLIAM A. GARVIN

JAN 30 2015

Executive Leaders Radio - February 11, 2015

EDWARD JOHN ALLERA JAMES C. WILTRAUT, JR.

OCT 14 2014

Executive Leaders Radio Show - February 5, 2014

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - December 11, 2013

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - November 20, 2013

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - October 23, 2013

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - September 18, 2013

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - June 26, 2013

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - May 17, 2013

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - January 30, 2013

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - October 24, 2012

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - June 20, 2012

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - February 29, 2012

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - November 16, 2011

EDWARD JOHN ALLERA

OCT 14 2014

Executive Leaders Radio Show - June 22, 2011

EDWARD JOHN ALLERA

JUN 11 2014

Executive Leaders Radio Show - June 11, 2014

EDWARD JOHN ALLERA

APR 23 2014

Executive Leaders Radio Show - April 23, 2014

EDWARD JOHN ALLERA

JAN 27 2014

FDA Issues Guidance on “Dear Healthcare Provider” Letters

EDWARD JOHN ALLERA

2017 TAX ACT ADVANCED TECHNOLOGY AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT ANTI-HARASSMENT & WORKPLACE CONDUCT TRAINING ANTITRUST & TRADE REGULATION APPELLATE ATTORNEY UPDATE AUTONOMOUS & CONNECTED VEHICLES BANKRUPTCY & CREDITORS' RIGHTS BLOCKCHAIN & DIGITAL ASSETS

MAR 12 2013

Beware the Ides of March

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA TINA HU-RODGERS WILLIAM A. GARVIN

2017 TAX ACT ADVANCED TECHNOLOGY AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT ANTI-HARASSMENT & WORKPLACE CONDUCT TRAINING ANTITRUST & TRADE REGULATION APPELLATE ATTORNEY UPDATE AUTONOMOUS & CONNECTED VEHICLES BANKRUPTCY & CREDITORS' RIGHTS BLOCKCHAIN & DIGITAL ASSETS

OCT 16 2012

A Wakeup Call from FDA

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

HEALTHCARE

OCT 15 2012

Medical Micropower Networks: Coming Soon to a Medical Device Near You?

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

HEALTHCARE

OCT 15 2012

Medical Body Area Networks (MBANs): A Promising Technology with Challenges and Risks

BARBARA A. BINZAK BLUMENFELD, PH.D. EDWARD JOHN ALLERA

FEB 8 2012

Sharp increase in threatened lawsuits against food and beverage clients

EDWARD JOHN ALLERA WILLIAM A. GARVIN

2017 TAX ACT ADVANCED TECHNOLOGY AFFORDABLE HOUSING AND COMMUNITY DEVELOPMENT ANTI-HARASSMENT & WORKPLACE CONDUCT TRAINING ANTITRUST & TRADE REGULATION APPELLATE ATTORNEY UPDATE AUTONOMOUS & CONNECTED VEHICLES BANKRUPTCY & CREDITORS' RIGHTS BLOCKCHAIN & DIGITAL ASSETS

APR 5 2011

The Nanotechnology Revolution: Are FDA and the Public Ready for It?

EDWARD JOHN ALLERA WILLIAM A. GARVIN

APR 5 2011

Healthcare Advertising and Reimbursement: Free Speech Protection But Not Unfettered

EDWARD JOHN ALLERA

APR 5 2011

Food & Drug/Biomedical Update: Changes to Paragraph IV Patent Certification in the Medicare Prescription Drug, Improvement, and Modernization Act

EDWARD JOHN ALLERA

INTELLECTUAL PROPERTY

MAR 1 2011

Wireless Technology/Device Use in the Health Care System

EDWARD JOHN ALLERA

AUG 20 2002

New Rule Covers Therapies Based on Cells, Tissues

EDWARD JOHN ALLERA